Using Historical Lesion Volume Data in the Design of a New Phase II Clinical Trial in Acute Stroke

John Whitehead(Lancaster City Council), Kennedy R. Lees(University of Graz), Anela Lihic(Lancaster University), Elsa Valdés‐Márquez(University of Reading), Myzoon Ali(University of Edinburgh), Kim Bolland(University of Reading)

Stroke

February 20, 2009

10.1161/strokeaha.108.531442

Cited by 15

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

|The Lancet|2014|2.7k

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

|New England Journal of Medicine|1986|1.5k

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

|The Lancet|2019|891

A general parametric approach to the meta‐analysis of randomized clinical trials

|Statistics in Medicine|1991|765

The Design and Analysis of Sequential Clinical Trials.

|Journal of the American Statistical Association|1985|638